Retatrutide is a triple agonist showing remarkable weight loss results in clinical trials. Learn how retatrutide works, its benefits, and what makes it differen
Retatrutide is a triple agonist showing remarkable weight loss results in clinical trials. Learn how retatrutide works, its benefits, and what makes it differen
Ready to stop GLP-1? Learn the safest way to discontinue GLP-1 medications, how to prevent weight regain, and what lifestyle changes help maintain your results
Ready to stop GLP-1? Learn the safest way to discontinue GLP-1 medications, how to prevent weight regain, and what lifestyle changes help maintain your results
Semaglutide and Tirzepatide are the two most powerful GLP-1 agonists for weight loss. Here is what the research actually shows about their differences.
Understand how GLP-1 medications interact with thyroid function, what research shows, and how to monitor your thyroid health during treatment.
The bupropion and naltrexone combination targets hunger and reward-driven eating through two distinct brain pathways. Here is what the evidence says about who it helps.
Retatrutide activates GLP-1, GIP, and glucagon simultaneously. Here is what the science says about this triple agonist and what it could mean for obesity treatment.
Weight commonly returns after stopping GLP-1 agonists. Understanding the biological mechanisms behind this effect and the strategies that help sustain results long-term.
Caloric deficit is the foundation of weight loss, but maintaining a sustainable deficit is challenging. Understand how peptides and GLP-1 affect this equation.
Feeling fatigued during peptide or GLP-1 treatment? Learn when it is normal, when to worry, and how to manage energy with sleep, hydration, and nutrition.
Learn how GLP-1 can help people with hypothyroidism on thyroid hormone replacement, including dose guidance and monitoring recommendations.